Lung Injury as an Immune-Related Adverse Event Following COVID-19 Pneumonia During Combination Therapy with Atezolizumab and Bevacizumab for Hepatocellular Carcinoma

Authors

Institutions

Publication Details

Journal
Kanzo
Published
2025-02-01
DOI
https://doi.org/10.2957/kanzo.66.39
Citations
1
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lung Injury as an Immune-Related Adverse Event Following COVID-19 Pneumonia During Combination Therapy with Atezolizumab and Bevacizumab for Hepatocellular Carcinoma

Kazunobu Aso, Koji Sawada, Shin Otake, Takumu Hasebe et al.
1 citations
Kanzo
COVID-19 Clinical Research Studies
1.40
article

Lung Injury as an Immune-Related Adverse Event Following COVID-19 Pneumonia During Combination Therapy with Atezolizumab and Bevacizumab for Hepatocellular Carcinoma

Kazunobu Aso, Koji Sawada, Shin Otake, Takumu Hasebe, Yukiho Tamura, Yu Ota, Shunsuke Nakajima, Mikihiro Fujiya, Hidemi Hayashi, Kazuki Muro
article en
1 citations

Abstract

No abstract available for this paper.
KanzoVol. 66(2)
Asahikawa Medical University (JP)
Good health and well-being
Openalex Percentile: Top 24%
COVID-19 Clinical Research Studies
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.